Brian Laden

Brian is a Co-founder and Partner at TriStar Technology Ventures, a venture capital investment group currently managing two early stage healthcare-focused funds totaling approximately $40 million. TriStar Technology Ventures is a part of the Healthcare Investment Group, consisting of three healthcare-focused investment funds with approximately $1 billion under management. With a primary focus across the life sciences, including medical devices, diagnostics and drug discovery, he sits on the Board of six portfolio companies and actively oversees TriStar’s interest in two others. Brian is also a founding director of Vertex Clinical Innovations, a company that provides technology transfer services to hospitals, health systems and universities. Prior to co-founding TriStar and Vertex, Brian served as the Assistant Director in the Office of Technology Transfer and Enterprise Development at Vanderbilt University. He is has also been active in the Association of University Technology Managers (AUTM), previously serving as the Associate Vice President and as a member of the Board of Directors. Prior to moving into technology transfer, Brian worked as a postdoctoral researcher in the Department of Biochemistry at Vanderbilt, where his work focused on structure-function studies of the cytochromes P450. He holds a doctorate in Molecular Toxicology from the University of Kentucky, a Master’s degree in Environmental and Industrial Health from the University of Michigan and an undergraduate degree in Biology from Penn State University.